Medical and Surgical Oncology Lecture: Optune in Newly Diagnosed Glioblastoma (GBM)

Optune in Newly Diagnosed Glioblastoma (GBM)

Glioblastoma is a devastating disease with a survival that is measured in months. The recent FDA approval of the Optune device for the treatment of newly-diagnosed glioblastoma was a paradigm shift in the field of neuro-oncology. We will focus our discussion on the biological underpinnings of this device and clinical data supporting its use.

Lecture Objectives:

• Understand the current outcomes and treatment of glioblastoma before the introduction of Optune

• Explain the mechanism of actions and early research that led to the approval of Optune by the FDA

• Describe the evolving role of Optune in the management of glioblastoma

To Receive FREE Continuing Education Credit for this Live Lecture:

• Attend the live lecture, either by going to a designated site or by using Zoom (registration link above).
• Be present in the lecture for a minimum of 50 minutes.
• After attending the live lecture, complete an evaluation and download your certificate.
• The instructions and password for the evaluation will be provided after the lecture is over.
• If you attend at a designated site, the site coordinator will provide you with the Live Activity Evaluation Instructions.
• If you attend via Zoom Webinar, you will receive an email 24 hours after the lecture with a link to the Live Activity Evaluation Instructions.
• Attendance at the live lecture is required to receive the Live Activity Evaluation Instructions.

Lecture Resources:

• Certification Pending Flyer ( JPEG | PDF )
• Presentation Handout (Coming Soon)
• Live Link (Livestream of lecture; recording available for viewing within 48 hours of lecture.)

UNCCN Site Coordinators:

Self-Paced, Online Courses with FREE Continuing Education Credit:

• This lecture will be available as a FREE Self-Paced, Online Course in October 2018. Please visit learn.unccn.org to peruse our many Self-Paced, Online Courses.